Zmora Oded, Neufeld David, Ziv Yehiel, Tulchinsky Hagit, Scott Dan, Khaikin Marat, Stepansky Albert, Rabau Micha, Koller Moshe
Department of Surgery, Sheba Medical Center, Tel Aviv, Israel.
Dis Colon Rectum. 2005 Dec;48(12):2167-72. doi: 10.1007/s10350-005-0199-1.
The surgical management of complex perianal fistulas is challenging and may be associated with the risk of sphincter injury. Instillation of fibrin glue to the fistula tract is a simple procedure that does not involve any muscle division, and potentially results in healing of the fistula. This study was designed to assess the use of highly concentrated fibrin glue with intra-adhesive antibiotics in the treatment of complex cryptogenic perianal fistulas.
Patients with complex perianal fistulas of cryptogenic origin were prospectively included in this multicenter study. Injection of the fibrin glue mixed with antibiotics was performed in a uniform fashion. After the procedure, patients were actively examined at fixed time intervals; in cases of recurrent fistula, reinjection of fibrin glue was offered.
Sixty patients were enrolled; complete healing of the fistula was achieved in 32 patients (53 percent). Eight of 28 patients (29 percent) who were not completely healed had significant symptomatic improvement. All patients resumed normal daily activity the day after surgery and none had any deterioration in continence related to the procedure. The majority of the 26 (43 percent) adverse events were considered mild and spontaneously resolved; 2 patients (3 percent) with perianal septic complications were successfully treated by drainage.
Injection of fibrin glue for the treatment of perianal fistulas is safe, simple, and associated with early return to normal activity. Although moderately successful, it may preclude extensive surgery in more than one-half of these patients.
复杂肛周瘘的外科治疗具有挑战性,且可能伴有括约肌损伤风险。向瘘管内注入纤维蛋白胶是一种简单的操作,不涉及任何肌肉分离,有可能使瘘管愈合。本研究旨在评估高浓度纤维蛋白胶联合黏附性抗生素在治疗复杂隐源性肛周瘘中的应用。
本多中心研究前瞻性纳入了患有复杂隐源性肛周瘘的患者。以统一方式进行纤维蛋白胶与抗生素混合液的注射。术后,定期对患者进行积极检查;对于复发性瘘管,再次提供纤维蛋白胶注射治疗。
共纳入60例患者;32例患者(53%)实现了瘘管完全愈合。28例未完全愈合的患者中有8例(29%)症状有显著改善。所有患者术后次日即恢复正常日常活动,且无一例因该操作导致控便能力恶化。26例(43%)不良事件中的大多数被认为较轻且可自行缓解;2例(3%)出现肛周感染并发症的患者通过引流成功治愈。
注射纤维蛋白胶治疗肛周瘘安全、简单,且能使患者早期恢复正常活动。尽管成功率中等,但在超过半数的此类患者中可避免进行广泛手术。